Investors in Hospira Inc saw new options begin trading today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HSP options chain for the new July contracts and identified one put and one call contract of particular interest.
LAKE FOREST, Ill., May 14, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that Sumant Ramachandra, M.D., Ph.D., ...
The market overreacted to the resignation of Synta's R&D chief.
Hospira was a leading decliner within the health care sector, falling $0.39 (-1.1%) to $34.23 on light volume